4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-23-000064
Chief Executive Officer returned 27,705 shares (to the company)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROSEN TERRY J · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-18 | Returned to the company : show line 1 in the form 10b5-1 | −13,705 | $17.74 | $243,127 | 3,880,526 | D |
| 2023-12-19 | Returned to the company : show line 2 in the form 10b5-1 | −14,000 | $18.09 | $253,260 | 3,866,526 | D |
Loading xslF345X05/wk-form4_1703106555.xml…